HPGC Renmintongtai Pharmaceutical Balance Sheet Health
Financial Health criteria checks 4/6
HPGC Renmintongtai Pharmaceutical has a total shareholder equity of CN¥2.8B and total debt of CN¥1.1B, which brings its debt-to-equity ratio to 37.7%. Its total assets and total liabilities are CN¥7.2B and CN¥4.4B respectively. HPGC Renmintongtai Pharmaceutical's EBIT is CN¥379.6M making its interest coverage ratio -112.4. It has cash and short-term investments of CN¥1.0B.
Key information
37.7%
Debt to equity ratio
CN¥1.06b
Debt
Interest coverage ratio | -112.4x |
Cash | CN¥1.02b |
Equity | CN¥2.80b |
Total liabilities | CN¥4.39b |
Total assets | CN¥7.19b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 600829's short term assets (CN¥6.7B) exceed its short term liabilities (CN¥4.2B).
Long Term Liabilities: 600829's short term assets (CN¥6.7B) exceed its long term liabilities (CN¥154.7M).
Debt to Equity History and Analysis
Debt Level: 600829's net debt to equity ratio (1.4%) is considered satisfactory.
Reducing Debt: 600829's debt to equity ratio has increased from 22.9% to 37.7% over the past 5 years.
Debt Coverage: 600829's operating cash flow is negative, therefore debt is not well covered.
Interest Coverage: 600829 earns more interest than it pays, so coverage of interest payments is not a concern.